New Delhi, India

Ashok Rattan

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • New Delhi, IN (2003 - 2004)
  • Delhi, IN (2005)
  • Haryana, IN (2009)

Company Filing History:


Years Active: 2003-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Ashok Rattan in Antimicrobial Research

Introduction

Ashok Rattan is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of antimicrobial research, holding a total of 5 patents. His work focuses on developing novel compounds that can combat various human and veterinary pathogens.

Latest Patents

Among his latest patents, Ashok Rattan has developed oxazolidinone derivatives as antimicrobials. These innovations include novel substituted phenyl oxazolidinones and processes for their synthesis. The pharmaceutical compositions derived from these compounds are effective against a range of pathogens, including gram-positive aerobic bacteria such as multiple-resistant staphylococci, streptococci, and enterococci, as well as anaerobic organisms and acid-fast organisms.

Another significant patent involves oxazolidinone piperazinyl derivatives as potential antimicrobials. This invention relates to certain substituted phenyl piperazinyl oxazolidinones, which are also effective against various pathogens. The pharmaceutical compositions containing these compounds serve as valuable antimicrobial agents.

Career Highlights

Ashok Rattan is associated with Ranbaxy Laboratories, Inc., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing antimicrobial therapies, contributing to public health and safety.

Collaborations

He collaborates with notable colleagues such as Biswajit Das and Sonali Rudra, enhancing the research and development efforts within his team.

Conclusion

Ashok Rattan's contributions to antimicrobial research through his patents reflect his commitment to improving healthcare solutions. His innovative work continues to pave the way for new treatments against resistant pathogens.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…